Results for tag: "Ventorlin Expectorant"

Ventorlin Expectorant is a type of respiratory medication commonly prescribed for the treatment of obstructive airway diseases such as asthma, chronic bronchitis, and emphysema. It combines the therapeutic effects of a bronchodilator with an expectorant. Bronchodilators work by relaxing and widening the air passages in the lungs, making it easier to breathe, while expectorants help loosen mucus in the lungs, enabling patients to cough it out more effectively. Such a dual-action medication is beneficial in managing symptoms like coughing, wheezing, and shortness of breath. Ventorlin Expectorant is part of the larger therapeutic category of respiratory drugs, which encompasses a range of treatments designed to address various disorders of the respiratory system. Companies that are active in the respiratory pharmaceutical market and may be involved in the production or distribution of medications like Ventorlin Expectorant include GlaxoSmithKline, Teva Pharmaceutical Industries, Boehringer Ingelheim, AstraZeneca, Merck & Co., and Novartis. These companies invest in the research and development of innovative drugs, as well as the manufacturing and marketing of existing treatments, to meet the needs of patients with respiratory conditions. Show Less Read more